Author:
Pieck A C, ,Drescher A,Wiesmann K G,Messerschmidt J,Weber G,Strumberg D,Hilger R A,Scheulen M E,Jaehde U
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Allain P, Brienza S, Gamelin R, Taamma A, Krikorian A, Turcant C, Cvitkovic E, Misset JL (1996) Oxaliplatin induced platinum DNA adducts in white blood cells of cancer patients. Proc Annu Meet Am Assoc Cancer Res 37: 404
2. André T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T, Topham C, Zaninelli M, Clingan P, Bridgewater J, Tabah-Fisch I, de Gramont A (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. New Engl J Med 350: 2343–2351
3. Boffetta P, Fichtinger-Schepman AM, Weiderpass E, van Dijk-Knijnenburg HC, Stoter G, van Oosterom AT, Keizer HJ, Fosså SD, Kaldor J, Roy P (1998) Cisplatin-DNA adducts and proteinbound platinum in blood of testicular cancer patients. Anticancer Drugs 9: 125–129
4. Bonetti A, Apostoli P, Zaninelli M, Pavanel F, Colombatti M, Cetto GL, Franceschi T, Sperotto L, Leone R (1996) Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy. Clin Cancer Res 2: 1829–1835
5. Cassidy J, Misset JL (2002) Oxaliplatin-related side effects: characteristics and management. Semin Oncol 29 (suppl 15): 11–20
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献